Protein Sciences: No Yolk

Protein Sciences Corp. believes its FluBlOk influenza vaccine, which is manufactured using the company's baculovirus protein expression system in an insect cell line, will be safer and less resource-intensive than the egg-based manufacturing process for marketed flu vaccines. Although Aventis S.A. returned rights to the vaccine in 2001, Protein Sciences now has positive Phase IIb data in hand showing that its recombinant flu vaccine

Read the full 644 word article

How to gain access

Continue reading with a
two-week free trial.